View Item 

Show simple item record

Trends and racial disparities in aggressive end‐of‐life care for a national sample of women with ovarian cancer
dc.contributor.authorMullins, Megan A.
dc.contributor.authorRuterbusch, Julie J.
dc.contributor.authorClarke, Philippa
dc.contributor.authorUppal, Shitanshu
dc.contributor.authorWallner, Lauren P.
dc.contributor.authorCote, Michele L.
dc.date.accessioned2021-07-01T20:13:05Z
dc.date.available2022-08-01 16:13:02en
dc.date.available2021-07-01T20:13:05Z
dc.date.issued2021-07-01
dc.identifier.citationMullins, Megan A.; Ruterbusch, Julie J.; Clarke, Philippa; Uppal, Shitanshu; Wallner, Lauren P.; Cote, Michele L. (2021). "Trends and racial disparities in aggressive end‐of‐life care for a national sample of women with ovarian cancer." Cancer (13): 2229-2237.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/168338
dc.publisherThe National Academies Press
dc.publisherWiley Periodicals, Inc.
dc.subject.otherracial disparity
dc.subject.otherterminal care
dc.subject.otherovarian cancer
dc.subject.otherhospice care
dc.titleTrends and racial disparities in aggressive end‐of‐life care for a national sample of women with ovarian cancer
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168338/1/cncr33488.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168338/2/cncr33488_am.pdf
dc.identifier.doi10.1002/cncr.33488
dc.identifier.sourceCancer
dc.identifier.citedreferenceTaylor JS, Brown AJ, Prescott LS, Sun CC, Ramondetta LM, Bodurka DC. Dying well: how equal is end of life care among gynecologic oncology patients? Gynecol Oncol. 2016; 140: 295 ‐ 300. doi: 10.1016/j.ygyno.2015.12.012
dc.identifier.citedreferenceWu E, Rogers A, Ji L, et al. Escalation of oncologic services at the end of life among patients with gynecologic cancer at an urban, public hospital. J Oncol Pract. 2015; 11: e163 ‐ e169. doi: 10.1200/JOP.2014.001529
dc.identifier.citedreferenceEarle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004; 22: 315 ‐ 321. doi: 10.1200/JCO.2004.08.136
dc.identifier.citedreferenceMorden NE, Chang C‐H, Jacobson JO, et al. End‐of‐life care for Medicare beneficiaries with cancer is highly intensive overall and varies widely. Health Aff (Millwood). 2012; 31: 786 ‐ 796. doi: 10.1377/hlthaff.2011.0650
dc.identifier.citedreferenceThe National Quality Forum. National Voluntary Consensus Standards for Quality of Cancer Care. The National Quality Forum; 2009. Accessed July 6, 2017. http://www.qualityforum.org/publications/2009/05/National_voluntary_consensus_standards_for_Quality_of_Cancer_Care.aspx
dc.identifier.citedreferenceAdamo M, Dickie L, Rhul J. SEER Program Coding and Staging Manual 2018. US Department of Health and Human Services; National Cancer Institute; 2018.
dc.identifier.citedreferenceKlabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000; 53: 1258 ‐ 1267.
dc.identifier.citedreferenceCharlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373 ‐ 383. doi: 10.1016/0021-9681(87)90171-8
dc.identifier.citedreferenceWang SY, Hsu SH, Huang S, Doan KC, Gross CP, Ma X. Regional practice patterns and racial/ethnic differences in intensity of end‐of‐life care. Health Serv Res. 2018; 53: 4291 ‐ 4309. doi: 10.1111/1475-6773.12998
dc.identifier.citedreferenceHuo J, Du XL, Lairson DR, et al. Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma. Am J Clin Oncol. 2015; 38: 235 ‐ 241. doi: 10.1097/COC.0b013e31829378f9
dc.identifier.citedreferenceNipp RD, Tramontano AC, Kong CY, Hur C. Patterns and predictors of end‐of‐life care in older patients with pancreatic cancer. Cancer Med. 2018; 7: 6401 ‐ 6410. doi: 10.1002/cam4.1861
dc.identifier.citedreferenceMargolis B, Chen L, Accordino MK, et al. Trends in end‐of‐life care and health care spending in women with uterine cancer. Am J Obstet Gynecol. 2017; 217: 434.e1 ‐ 434.e10. doi: 10.1016/j.ajog.2017.07.006
dc.identifier.citedreferenceTramontano AC, Nipp R, Kong CY, Yerramilli D, Gainor JF, Hur C. Hospice use and end‐of‐life care among older patients with esophageal cancer. Health Sci Rep. 2018; 1: e76. doi: 10.1002/hsr2.76
dc.identifier.citedreferenceBarnato AE, Berhane Z, Weissfeld LA, et al. Racial variation in end‐of‐life intensive care use: a race or hospital effect? Health Serv Res. 2006; 41: 2219 ‐ 2237. doi: 10.1111/j.1475-6773.2006.00598.x
dc.identifier.citedreferenceBarnato AE, Herndon MB, Anthony DL, et al. Are regional variations in end‐of‐life care intensity explained by patient preferences? Med Care. 2007; 45: 386 ‐ 393. doi: 10.1097/01.mlr.0000255248.79308.41
dc.identifier.citedreferenceGallo JJ, Andersen MS, Hwang S, Meoni L, Jayadevappa R. Physician preferences for aggressive treatment at the end of life and area‐level health care spending: the Johns Hopkins Precursors Study. Gerontol Geriatr Med. 2017; 3: 2333721417722328. doi: 10.1177/2333721417722328
dc.identifier.citedreferenceLoPresti MA, Dement F, Gold HT. End‐of‐life care for people with cancer from ethnic minority groups: a systematic review. Am J Hosp Palliat Care. 2016; 33: 291 ‐ 305. doi: 10.1177/1049909114565658
dc.identifier.citedreferenceWright AA, Zhang B, Ray A, et al. Associations between end‐of‐life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008; 300: 1665 ‐ 1673. doi: 10.1001/jama.300.14.1665
dc.identifier.citedreferenceObermeyer Z, Makar M, Abujaber S, Dominici F, Block S, Cutler DM. Association between the Medicare hospice benefit and health care utilization and costs for patients with poor‐prognosis cancer. JAMA. 2014; 312: 1888 ‐ 1896. doi: 10.1001/jama.2014.14950
dc.identifier.citedreferenceCenters for Medicare and Medicaid. Evaluation of the Oncology Care Model: Performance Periods 1‐3. Accessed September 14, 2020. https://innovation.cms.gov/data-and-reports/2020/ocm-evaluation-annual-report-2
dc.identifier.citedreferenceCenters for Medicare and Medicaid. Evaluation of the Oncology Care Model: Performance Period One. Accessed September 14, 2020. https://innovation.cms.gov/files/reports/ocm-secondannualeval-pp1.pdf
dc.identifier.citedreferenceGilstrap L, Huskamp HA, Stevenson DG, Chernew ME, Grabowski DC, McWilliams JM. Changes in end‐of‐life care in the Medicare shared savings program. Health Aff (Millwood). 2018; 37: 1693 ‐ 1700. doi: 10.1377/hlthaff.2018.0491
dc.identifier.citedreferenceDzeng E, Dohan D, Curtis JR, Smith TJ, Colaianni A, Ritchie C. Homing in on the social: systems‐level influences on overly aggressive treatments at the end of life. J Pain Symptom Manage. 2018; 55 ( 2 ): 282 ‐ 289.e1. doi: 10.1016/j.jpainsymman.2017.08.019
dc.identifier.citedreferenceShinn EH, Carmack Taylor CL, Kilgore K, et al. Associations with worry about dying and hopelessness in ambulatory ovarian cancer patients. Palliat Support Care. 2009; 7: 299 ‐ 306. doi: 10.1017/S1478951509990228
dc.identifier.citedreferencePark HK, Ruterbusch JJ, Cote ML. Recent trends in ovarian cancer incidence and relative survival in the United States by race/ethnicity and histologic subtypes. Cancer Epidemiol Biomarkers Prev. 2017; 26: 1511 ‐ 1518. doi: 10.1158/1055-9965.EPI-17-0290
dc.identifier.citedreferenceAbedini NC, Hechtman RK, Singh AD, et al. Interventions to reduce aggressive care at end of life among patients with cancer: a systematic review. Lancet Oncol. 2019; 20: e627 ‐ e636. doi: 10.1016/S1470-2045(19)30496-6
dc.identifier.citedreferenceSurveillance, Epidemiology, and End Results Program; National Cancer Institute. Cancer Stat Facts: Ovarian Cancer. Accessed September 14, 2020. https://seer.cancer.gov/statfacts/html/ovary.html
dc.identifier.citedreferenceCommittee on Approaching Death: Addressing Key End‐of‐Life Issues; Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. The National Academies Press; 2015.
dc.identifier.citedreferenceThe National Quality Forum. NQF‐Endorsed Palliative Care and End of Life Care Endorsement Maintenance Standards. Accessed February 20, 2020. https://www.qualityforum.org/Projects/n-r/Palliative_Care_and_End-of-Life_Care/Table_of_Measures.aspx
dc.identifier.citedreferenceEarle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: is it a quality‐of‐care issue? J Clin Oncol. 2008; 26: 3860 ‐ 3866. doi: 10.1200/JCO.2007.15.8253
dc.identifier.citedreferenceEarle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S. Identifying potential indicators of the quality of end‐of‐life cancer care from administrative data. J Clin Oncol. 2003; 21: 1133 ‐ 1138. doi: 10.1200/JCO.2003.03.059
dc.identifier.citedreferenceWright AA, Hatfield LA, Earle CC, Keating NL. End‐of‐life care for older patients with ovarian cancer is intensive despite high rates of hospice use. J Clin Oncol. 2014; 32: 3534 ‐ 3539. doi: 10.1200/JCO.2014.55.5383
dc.identifier.citedreferenceTaylor JS, Rajan SS, Zhang N, et al. End‐of‐life racial and ethnic disparities among patients with ovarian cancer. J Clin Oncol. 2017; 35: 1829 ‐ 1835. doi: 10.1200/JCO.2016.70.2894
dc.identifier.citedreferenceFairfield KM, Murray KM, Wierman HR, et al. Disparities in hospice care among older women dying with ovarian cancer. Gynecol Oncol. 2012; 125: 14 ‐ 18. doi: 10.1016/j.ygyno.2011.11.041
dc.identifier.citedreferenceBrown AJ, Sun CC, Prescott LS, Taylor JS, Ramondetta LM, Bodurka DC. Missed opportunities: patterns of medical care and hospice utilization among ovarian cancer patients. Gynecol Oncol. 2014; 135: 244 ‐ 248. doi: 10.1016/j.ygyno.2014.08.039
dc.identifier.citedreferenceFerris FD, Bruera E, Cherny N, et al. Palliative cancer care a decade later: accomplishments, the need, next steps—from the American Society of Clinical Oncology. J Clin Oncol. 2009; 27: 3052 ‐ 3058. doi: 10.1200/JCO.2008.20.1558
dc.identifier.citedreferencePeppercorn JM, Smith TJ, Helft PR, et al. American Society of Clinical Oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol. 2011; 29: 755 ‐ 760. doi: 10.1200/JCO.2010.33.1744
dc.identifier.citedreferenceWarren J, Klabunde C, Schrag D, Bach P, Riley G. Overview of the SEER‐Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002; 40: 3 ‐ 18.
dc.identifier.citedreferencePotosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare‐tumor registry database. Med Care. 1993; 31: 732 ‐ 748.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr33488.pdf
Size:
388.1KB
Format:
PDF
View/Open
Name:
cncr33488_am.pdf
Size:
597.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.